Tscan Therapeutics shares owned by Privium Fund Management
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Privium Fund Management
from 13F filings
Historical chart of Privium Fund Management investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Privium Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tscan Therapeutics by Privium Fund Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $127k | 16k | 8.01 |
2023-09-30 | $42k | 16k | 2.62 |
2023-06-30 | $40k | 16k | 2.53 |
2023-03-31 | $41k | 16k | 2.59 |
2022-12-31 | $25k | 16k | 1.55 |
2022-09-30 | $48k | 16k | 3.03 |